Human Melanoma: Drug Resistance
Advanced malignant melanoma has a poor prognosis since chemotherapy is mostly ineffective because, in part, of the intrinsic and/or extrinsic resistance of melanoma cells to systemic treatment with antineoplastic agents. The reasons for the chemoresistant phenotype are currently unknown. The relevan...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Chapter/Article Conference Paper |
| Language: | English |
| Published: |
2003
|
| In: |
Chemosensitivity Testing in Oncology
Year: 2003, Pages: 93-110 |
| DOI: | 10.1007/978-3-642-19022-3_9 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/978-3-642-19022-3_9
|
| Author Notes: | Heike Helmbach, Pranav Sinha, Dirk Schadendorf |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1739023382 | ||
| 003 | DE-627 | ||
| 005 | 20230426122339.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201118s2003 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/978-3-642-19022-3_9 |2 doi | |
| 035 | |a (DE-627)1739023382 | ||
| 035 | |a (DE-599)KXP1739023382 | ||
| 035 | |a (OCoLC)1341377812 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Röckmann, Heike |d 1973- |e VerfasserIn |0 (DE-588)120325411 |0 (DE-627)696570963 |0 (DE-576)292160399 |4 aut | |
| 245 | 1 | 0 | |a Human Melanoma |b Drug Resistance |c Heike Helmbach, Pranav Sinha, Dirk Schadendorf |
| 264 | 1 | |c 2003 | |
| 300 | |a 18 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 18.11.2020 | ||
| 520 | |a Advanced malignant melanoma has a poor prognosis since chemotherapy is mostly ineffective because, in part, of the intrinsic and/or extrinsic resistance of melanoma cells to systemic treatment with antineoplastic agents. The reasons for the chemoresistant phenotype are currently unknown. The relevance of well-analyzed drug resistance mechanisms in melanoma such as intracellular and extracellular transport, drug resistance by induction of certain enzyme systems, and altered drug-target interaction is reviewed. It has been shown that most anticancer drugs kill susceptible cells through induction of apoptosis. Therefore, the significance of apoptotic deficiency caused by alteration in the apoptotic pathway is discussed in relation to specific molecules and apoptotic mechanisms like death-receptors, the Bcl-2 family, and the Hsp family of proteins. The complexity of the molecular variants involved in signal transduction along apoptotic pathways suggests that the cell may possess a variety of possibilities for regulating apoptosis and generating apoptosis deficiency. Thus apoptosis and apoptosis deficiency should be analyzed to understand the mechanisms of melanoma resistance. | ||
| 700 | 1 | |a Sinha-von Jaschke, Pranav |d 1951- |e VerfasserIn |0 (DE-588)111913438 |0 (DE-627)691131627 |0 (DE-576)289715881 |4 aut | |
| 700 | 1 | |a Schadendorf, Dirk |d 1960- |e VerfasserIn |0 (DE-588)11142576X |0 (DE-627)499566076 |0 (DE-576)289702275 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |a Reinhold, Uwe, 1960 - |t Chemosensitivity Testing in Oncology |d Berlin : Springer, 2003 |g (2003), Seite 93-110 |h Online-Ressource (X, 245 p) |w (DE-627)749193158 |w (DE-576)9749193156 |z 9783642190223 |7 nnam |
| 773 | 1 | 8 | |g year:2003 |g pages:93-110 |g extent:18 |a Human Melanoma Drug Resistance |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-642-19022-3_9 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20201118 | ||
| 993 | |a ConferencePaper | ||
| 994 | |a 2003 | ||
| 998 | |g 11142576X |a Schadendorf, Dirk |m 11142576X:Schadendorf, Dirk |d 50000 |e 50000PS11142576X |k 0/50000/ |p 3 |y j | ||
| 999 | |a KXP-PPN1739023382 |e 380661900X | ||
| BIB | |a Y | ||
| JSO | |a {"name":{"displayForm":["Heike Helmbach, Pranav Sinha, Dirk Schadendorf"]},"origin":[{"dateIssuedKey":"2003","dateIssuedDisp":"2003"}],"id":{"eki":["1739023382"],"doi":["10.1007/978-3-642-19022-3_9"]},"physDesc":[{"extent":"18 S."}],"relHost":[{"id":{"isbn":["9783642190223"],"doi":["10.1007/978-3-642-19022-3"],"eki":["749193158"]},"origin":[{"publisherPlace":"Berlin ; Heidelberg","dateIssuedDisp":"2003","dateIssuedKey":"2003","publisher":"Springer"}],"name":{"displayForm":["edited by Uwe Reinhold, Wolfgang Tilgen"]},"physDesc":[{"extent":"Online-Ressource (X, 245 p)","noteIll":"digital"}],"title":[{"title_sort":"Chemosensitivity Testing in Oncology","title":"Chemosensitivity Testing in Oncology"}],"person":[{"role":"aut","display":"Reinhold, Uwe","given":"Uwe","family":"Reinhold"},{"family":"Tilgen","given":"Wolfgang","display":"Tilgen, Wolfgang","role":"oth"}],"part":{"extent":"18","text":"(2003), Seite 93-110","pages":"93-110","year":"2003"},"recId":"749193158","language":["eng"],"type":{"bibl":"book","media":"Online-Ressource"},"disp":"Reinhold, Uwe, 1960 - Chemosensitivity Testing in Oncology"}],"person":[{"given":"Heike","family":"Röckmann","role":"aut","roleDisplay":"VerfasserIn","display":"Röckmann, Heike"},{"family":"Sinha-von Jaschke","given":"Pranav","display":"Sinha-von Jaschke, Pranav","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Dirk","family":"Schadendorf","role":"aut","roleDisplay":"VerfasserIn","display":"Schadendorf, Dirk"}],"title":[{"subtitle":"Drug Resistance","title":"Human Melanoma","title_sort":"Human Melanoma"}],"note":["Gesehen am 18.11.2020"],"type":{"media":"Online-Ressource","bibl":"chapter"},"recId":"1739023382","language":["eng"]} | ||
| SRT | |a ROECKMANNHHUMANMELAN2003 | ||